SOLLAZZO, DARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.112
AS - Asia 1.606
EU - Europa 1.255
AF - Africa 92
Continente sconosciuto - Info sul continente non disponibili 92
SA - Sud America 63
OC - Oceania 7
Totale 5.227
Nazione #
US - Stati Uniti d'America 2.075
VN - Vietnam 489
SG - Singapore 408
CN - Cina 362
GB - Regno Unito 302
IT - Italia 220
SE - Svezia 212
DE - Germania 159
HK - Hong Kong 101
IN - India 87
FR - Francia 78
IE - Irlanda 58
RU - Federazione Russa 58
BR - Brasile 41
FI - Finlandia 33
BD - Bangladesh 29
CA - Canada 27
ZA - Sudafrica 26
EE - Estonia 23
JP - Giappone 23
TG - Togo 23
BG - Bulgaria 21
JO - Giordania 19
NL - Olanda 18
UA - Ucraina 18
BE - Belgio 16
CI - Costa d'Avorio 15
CH - Svizzera 13
KR - Corea 12
PH - Filippine 12
NG - Nigeria 11
AR - Argentina 10
TW - Taiwan 10
TH - Thailandia 9
IR - Iran 8
MY - Malesia 8
AU - Australia 6
TR - Turchia 5
AT - Austria 4
DZ - Algeria 4
EC - Ecuador 4
ID - Indonesia 4
IQ - Iraq 4
MX - Messico 4
PL - Polonia 4
RO - Romania 4
SA - Arabia Saudita 4
SC - Seychelles 4
LB - Libano 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ES - Italia 2
ET - Etiopia 2
GT - Guatemala 2
IL - Israele 2
LT - Lituania 2
NO - Norvegia 2
PE - Perù 2
PK - Pakistan 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
KY - Cayman, isole 1
LY - Libia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.135
Città #
Singapore 270
Southend 250
Chandler 224
Ashburn 223
Fairfield 194
San Jose 111
Dong Ket 109
Hong Kong 100
Woodbridge 99
Houston 91
Seattle 90
Ho Chi Minh City 84
Cambridge 82
Wilmington 70
Hanoi 67
Beijing 64
Ann Arbor 63
Princeton 61
Dublin 58
Santa Clara 58
Bologna 45
Boardman 36
Cornaredo 32
Lauterbourg 29
Helsinki 27
Council Bluffs 26
Redmond 26
Bremen 25
New York 25
Westminster 25
Lomé 23
Los Angeles 23
Nanjing 23
Sofia 21
Jinan 20
Tokyo 20
Amman 19
Padova 19
Berlin 18
Turin 17
Brussels 16
Abidjan 15
Dallas 15
Hefei 15
Milan 14
Munich 13
Redondo Beach 13
Saint Petersburg 12
Shenyang 12
Abeokuta 11
Changsha 11
Medford 11
Buffalo 10
Da Nang 10
Falls Church 10
Florence 10
Haiphong 10
Hyderabad 10
Bern 9
Frankfurt am Main 9
Nanchang 9
San Diego 9
Guangzhou 8
London 8
Kuala Lumpur 7
Redwood City 7
Seoul 7
Shanghai 7
São Paulo 7
Fremont 6
Hangzhou 6
Hebei 6
Montreal 6
Orem 6
Rome 6
Suzhou 6
Tianjin 6
Turku 6
Zhengzhou 6
Toronto 5
Winnipeg 5
Baltimore 4
Brooklyn 4
Chicago 4
Des Moines 4
Jiaxing 4
Leawood 4
Nuremberg 4
Paris 4
Pune 4
Quận Bình Thạnh 4
San Francisco 4
Stockholm 4
Taiyuan 4
Xi'an 4
Zanjan 4
Andover 3
Bangkok 3
Basingstoke 3
Biên Hòa 3
Totale 3.314
Nome #
Circulating calreticulin is increased in myelofibrosis: Correlation with interleukin-6 plasma levels, bone marrow fibrosis, and splenomegaly 265
CIRCULATING CD34+ STEM/PROGENITOR CELLS FROM TRIPLE NEGATIVE PATIENTS WITH MYELOFIBROSIS SHOW DIFFERENT NUMBER, GENE EXPRESSION PROFILE AND IN VITRO RESPONSE TO INFLAMMATORY STIMULI AS COMPARED WITH THE JAK2(V617F) MUTATED COUNTERPARTS 233
CIRCULATING PLATELET AND MEGAKARYOCYTE-DERIVED MICROPARTICLES OF JAK2V617F MUTATED PATIENTS WITH MYELOFIBROSIS ARE DISREGULATED: A NOVEL LIQUID BIOPSY TOOL OF RESPONSE TO RUXOLITINIB? 229
STUDIO DELLA FUNZIONE E DEL PROFILO DEI MICRORNA IN MICROPARTICELLE CIRCOLANTI ISOLATE DA PAZIENTI ‘TRIPLI NEGATIVI’ E JAK2V617F MUTATI CON MIELOFIBROSI 211
Mobilized Peripheral Blood versus Cord Blood: Insight into the distinct role of proinflammatory cytokines on survival, clonogenic ability, and migration of CD34+ cells 208
Bleeding in essential thrombocythaemia: a retrospective analysis on 565 patients 207
Circulating Platelet Vs Megakaryocyte-Derived Microparticles Identify Myelofibrosis Patients with JAK2V617F Mutation, High Disease Burden and Ruxolitinib Response 205
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 201
Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis 199
Crucial factors of the inflammatory microenvironment (IL-1β/ TNF-α/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study 194
TOWARD THE IDENTIFICATION OF A MICRORNA-BASED SIGNATURE OF CIRCULATING MICROPARTICLES FROM TRIPLE NEGATIVE AND JAK2(V617F) MUTATED PATIENTS WITH MYELOFIBROSIS 193
Circulating CD4+CD25-Foxp3+ cells are increased in patients with immune thrombocytopenia 188
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function 184
Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis 183
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia 182
Molecular and functional characterization of CD133+stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 182
Crucial Factors of the Inflammatory Microenvironment (IL-1 beta/TNF-alpha/TIMP-1) Promote Maintenance of the Malignant Hemopoietic Clone of Myelofibrosis By Stimulating the in Vitro Survival/Proliferation/Migration of Circulating CD34+ stem/Progenitor Cells 171
CD 133+ stem cells for the treatment of end stage liver disease. 165
MYH9-related thrombocytopenia and intracranial bleedings: a complex clinical/surgical management and review of the literature 143
The choice of second-line therapy in steroid-resistant immune thrombocytopenia: Role of platelet kinetics in a single-centre long-term study 143
Platelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosis 136
Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia. 132
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients 130
The CD47 pathway is deregulated in human immune thrombocytopenia 123
Circulating CD4+CD161+CD196+ Th17 cells are not increased in immune thrombocytopenia 116
CD133+ hematopoietic stem cells reinfusion in end-stage liver disease (ESLD): final results of a phase I clinical trial 110
CD133+ stem cells for the treatment of end-stage liver disease 108
null 107
null 98
null 96
Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years 95
Reinfusion of highly purified CD133+ stem cells in patients with end-stage liver disease (ESLD): final results of a phase I clinical trial 90
Totale 5.227
Categoria #
all - tutte 14.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.646


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022638 0 45 28 78 60 20 12 36 24 76 141 118
2022/2023780 82 116 47 107 50 61 18 48 130 35 63 23
2023/2024189 19 29 11 35 12 41 4 13 5 5 8 7
2024/2025583 39 70 52 55 78 23 32 25 35 40 19 115
2025/20261.408 117 85 91 86 143 59 148 88 353 125 78 35
2026/202794 49 45 0 0 0 0 0 0 0 0 0 0
Totale 5.227